- Ovarian Cancer
- Breast Cancer
- Per NCCN guidelines, any woman of Ashkenazi Jewish ancestry who has been diagnosed with breast or ovarian cancer meets criteria for BRCA founder variant testing.
- Verification of a genetic basis for cancer in families indicative or suggestive of hereditary breast and ovarian cancer.
- Determination of appropriate screening and treatment.
- Identification of at-risk family members.
- Capillary Sequencing
*The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
**Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.
Targeted Variant Testing